OTC Medicines

Browse OTC Medicines Content

Consumer Healthcare Products Association (CHPA) President and CEO, Scott Melville, today released a statement in response to the National Academies of Sciences, Engineering, and Medicine’s report titled Review of Fate, Exposure, and Effects of Sunscreens in Aquatic Environments and Implications for Sunscreen Usage and Human Health.

Aug 9, 2022

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Aug 3, 2022

This past week, the House of Representatives adjourned for its annual August recess, although the House Democratic Leadership indicated that members would be called back sometime in August, should the Senate pass the Inflation Reduction Act of 2022.

Aug 2, 2022

When it comes to self-care solutions, pharmacists can be an overlooked resource. Today we speak with Dr. Wendy Mobley-Bukstein, Associate Professor of Pharmacy Practice at Drake University about how pharmacists are playing bigger and critical roles in the self-care ecosystem.

Jul 25, 2022

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Jul 20, 2022

House and Senate negotiators are at odds over how to move forward with the FDA user fee reauthorization now that Senate HELP Committee Ranking Member, Senator Richard Burr (R-N.C.) is pushing a significantly pared-down version of the user fee reauthorization bill.

Jul 19, 2022

CHPA’s President and CEO, Scott Melville, today released a statement in response to news of HRA Pharma’s application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the United States.

Jul 11, 2022

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Jul 6, 2022

Now that the House of Representatives and the Senate HELP Committee have passed their respective FDA user fee bills, House and Senate negotiators have been working to conference and reconcile differences in both bills.

Jul 6, 2022

Filter Results